Mogito Open Access Journals of Oncology & Cancer Studies (MJOCS) Publication Ethics
At the Mogito Open Access Journal of Oncology and Cancer Studies (MJOCS), we are committed to the highest standards of ethics, transparency, and academic integrity in oncology publishing. Our publication ethics policy defines the responsibilities of authors, editors, peer reviewers, and the publisher, ensuring that all published research maintains credibility, reliability, and scientific rigor.
MJOCS upholds ethical standards across all aspects of oncology research, promoting trustworthy, high-quality publications that advance cancer science, clinical care, and global health outcomes.
MJOCS Publication Ethics: Upholding Integrity in Oncology Research
Mogito Open Access Journal of Oncology and Cancer Studies (MJOCS) is committed to the highest standards of ethics, transparency, and academic integrity in cancer research publishing. This policy defines the responsibilities of authors, editors, peer reviewers, and the publisher, ensuring that all published research is credible, reliable, and scientifically rigorous.
1. Ethical Responsibilities of Authors
Originality & Plagiarism
All manuscripts must be original and properly cited. MJOCS uses plagiarism detection tools to verify authenticity. Plagiarism, data fabrication, or duplicate publication is strictly prohibited and may result in rejection, retraction, or further investigation.
Authorship Criteria
Only individuals who have made substantial intellectual or practical contributions—including study design, clinical investigation, data analysis, or manuscript preparation—may be listed as authors. All authors must approve the final manuscript.
Data Accuracy & Transparency
Authors must present accurate, complete, and reproducible data. Falsified or fabricated results will lead to rejection, potential retraction, and investigation. Original datasets may be requested during peer review.
Conflict of Interest Disclosure
All authors must disclose financial, institutional, or personal conflicts of interest that could influence the research. Full transparency is mandatory.
Ethical Approval & Consent
Research involving humans, clinical data, or biological specimens must have ethical approval from a recognized board. Informed consent must be obtained and documented for all participants.
2. Responsibilities of Editors
Editorial Independence
Editors make decisions based solely on scientific quality, clinical relevance, and originality, free from commercial, political, or institutional influence.
Fair & Timely Peer Review
All submissions undergo rigorous double-blind peer review. Editors ensure fair, unbiased, and respectful evaluation.
Confidentiality
Editors must maintain confidentiality and may not use or disclose manuscript content prior to publication.
Managing Conflicts
Editors must declare conflicts of interest and recuse themselves when impartiality is compromised. Manuscripts will be reassigned to unbiased editors.
3. Responsibilities of Peer Reviewers
Objective Review
Reviewers provide constructive, fair, and objective feedback based solely on scientific merit and relevance. Personal opinions or offensive language are prohibited.
Confidentiality
All manuscripts under review are confidential. Reviewers may not share or use unpublished data for personal gain.
Disclosure of Conflicts
Reviewers must disclose any conflicts of interest and decline review if impartiality cannot be maintained.
4. Publisher Responsibilities
MJOCS, published by Mogito Open Access Journals, adheres to COPE standards and is committed to:
- Upholding editorial and academic independence
- Supporting global access to high-quality cancer research
- Ensuring data and authorship transparency
- Investigating and addressing ethical misconduct
5. Handling Research Misconduct
MJOCS investigates all allegations including:
- Plagiarism or duplicate publication
- Data manipulation or fabrication
- Unethical treatment of human or animal subjects
- Authorship disputes
Investigations are confidential, and confirmed misconduct may lead to rejection, retraction, or formal notice.
6. Retraction & Correction Policy
To maintain the integrity of oncology literature, MJOCS uses:
- Erratum – Minor factual errors
- Corrigendum – Author-requested corrections
- Retraction – Ethical breaches or major flaws
All notices are clearly labeled and linked to the original article.
Commitment to Integrity
MJOCS believes ethical publishing drives the advancement of cancer research and patient care. Authors, reviewers, editors, and readers are encouraged to uphold these principles at every stage of publication.
Report Concerns or Misconduct
📧 Email: mjocs@mogitojournals.org
🌐 Website: www.mogitojournals.org
To celebrate the launch of MJOCS, the first 10 accepted manuscripts will be published free of charge.
Submit now and enjoy open access publishing at no cost.
Ready to Publish Your Research
We’re here to guide you through every step of your publishing journey—from submission to global reach..
Let’s advance knowledge and discovery—together.
When connected with us, you aren’t growing your business alone. We have your back and put in our best to contribute to the growth of your entire team and organization. So, if you are “When you publish with us, you’re not navigating the process alone. Our editorial team is committed to supporting you through peer review, publication, and global dissemination. If you’re looking for the right platform to share your research, enhance visibility, and make a meaningful impact—Mogito is here for you.”